Lilly Advances IL-23, Gastroenterology Ambitions With Mirikizumab In Crohn's Disease

 
• By Mandy Jackson
  
Crohn's disease (gastrointestinal disease) diagnosis medical concept on tablet screen with stethoscope. - Image
Mirikizumab could be the second IL-23 inhibitor for IBD indications. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D